首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1981010

全球心臟生物醫學植入設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Cardiac Bio Implant Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: 2026年02月23日 | 出版商:

Value Market Research | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計心臟生物植入設備市場將從 2025 年的 647.9 億美元成長到 2034 年的 1,599.1 億美元，2026 年至 2034 年的複合年成長率為 10.56%。

隨著心血管疾病在全球範圍內的日益流行，心臟生物植入器械的全球市場正在迅速擴張。冠狀動脈疾病、心臟衰竭和心律不整等疾病的發生率不斷攀升，尤其是在高齡化社會。心臟植入，包括生物可吸收支架、心臟瓣膜和組織工程植入，旨在恢復心臟功能並改善患者預後。

生物材料和再生醫學領域的技術創新正顯著推動市場成長。研究人員正在開發模擬天然組織並促進體內癒合的生物工程植入。這些裝置可減少傳統植入相關的併發症，並提高長期治療成功率。對心血管研發投入的增加進一步加速了市場發展。

展望未來，心臟生物植入器材市場有望受益於組織工程和個人化醫療的進步。人們對早期心臟介入的認知不斷提高，以及發展中地區醫療基礎設施的改善，也將促進其應用。隨著技術的不斷發展，植入器械有望在未來的心血管治療中發揮關鍵作用。

區域分析
北美市場分析、洞察與預測
- 美國
- 加拿大
- 墨西哥
歐洲市場分析、洞察與預測
- 英國
- 法國
- 德國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太市場分析、洞察與預測
- 印度
- 日本
- 韓國
- 澳洲
- 東南亞
- 其他亞太國家
拉丁美洲市場分析、洞察與預測
- 巴西
- 阿根廷
- 秘魯
- 智利
- 其他拉丁美洲國家
中東和非洲市場分析、洞察與預測
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 其他中東和非洲國家

第8章競爭情勢

最新趨勢
公司分類
供應鏈和銷售管道合作夥伴（根據現有資訊）
市場佔有率和市場定位分析（基於現有資訊）
供應商情況（基於現有資訊）
策略規劃

第9章：公司簡介

主要公司的市佔率分析
公司簡介
- Abbott
- Edwards Lifesciences Corporation
- Johnson & Johnson Services Inc
- LivaNova PLC
- Medtronic
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- Mayo Foundation For Medical Education And Research（MFMER）
- ClearPoint Neuro Inc
- Imricor
- Biotronik
- Elestim-Cardio

簡介目錄

Product Code: VMR112115515

The Cardiac Bio Implant Devices Market size is expected to reach USD 159.91 Billion in 2034 from USD 64.79 Billion (2025) growing at a CAGR of 10.56% during 2026-2034.

The global cardiac bio implant devices market is expanding rapidly due to the rising prevalence of cardiovascular diseases worldwide. Conditions such as coronary artery disease, heart failure, and arrhythmias are becoming increasingly common, particularly among aging populations. Cardiac bio implants, including bioresorbable stents, heart valves, and tissue-engineered implants, are designed to restore cardiac function and improve patient outcomes.

Technological innovations in biomaterials and regenerative medicine are significantly influencing market growth. Researchers are developing bioengineered implants that mimic natural tissue and promote healing within the body. These devices reduce complications associated with traditional implants and improve long-term treatment success. Increased investment in cardiovascular research and medical device development is further accelerating market progress.

Looking forward, the cardiac bio implant devices market is expected to benefit from advancements in tissue engineering and personalized medicine. Growing awareness about early cardiac intervention and improved healthcare infrastructure in developing regions will also support adoption. As technology continues to evolve, bio implant devices are expected to play a critical role in future cardiovascular treatments.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

Structural Cardiac Implants
Stents and Related Implants
A Pacing Device

By Disease

Myocardial Ischemia
Acute Myocardial Infarction
Arrhythmias
Congestive Heart Failure (CHF)
Angina Pectoris (AP)
Cardiomyopathy
Aortic Aneurism
Others

By Procedure

Angioplasty
Heart Valve Repair or Replacement
Open Heart Surgery
Minimally Invasive Heart Surgery
Cardiac Resynchronization Therapy (CRT)
Others

COMPANIES PROFILED

Abbott, Edwards Lifesciences Corporation, Johnson Johnson Services Inc, LivaNova PLC, Medtronic, Boston Scientific Corporation, MicroPort Scientific Corporation, Mayo Foundation for Medical Education and Research MFMER, ClearPoint Neuro Inc, Imricor, Biotronik, ElestimCardio
We can customise the report as per your requirements.

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC BIO IMPLANT DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Product
4.2. Structural Cardiac Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Stents and Related Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. A Pacing Device Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC BIO IMPLANT DEVICES MARKET: BY DISEASE 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Disease
5.2. Myocardial Ischemia Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Acute Myocardial Infarction Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Arrhythmias Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Congestive Heart Failure (CHF) Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Angina Pectoris (AP) Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.7. Cardiomyopathy Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.8. Aortic Aneurism Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC BIO IMPLANT DEVICES MARKET: BY PROCEDURE 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Procedure
6.2. Angioplasty Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Heart Valve Repair or Replacement Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Open Heart Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Minimally Invasive Heart Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.6. Cardiac Resynchronization Therapy (CRT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIAC BIO IMPLANT DEVICES MARKET: BY REGION 2022-2034(USD MN)

7.1. Regional Outlook
7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product
- 7.2.2 By Disease
- 7.2.3 By Procedure
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product
- 7.3.2 By Disease
- 7.3.3 By Procedure
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product
- 7.4.2 By Disease
- 7.4.3 By Procedure
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product
- 7.5.2 By Disease
- 7.5.3 By Procedure
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product
- 7.6.2 By Disease
- 7.6.3 By Procedure
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

8.1. Recent Developments
8.2. Company Categorization
8.3. Supply Chain & Channel Partners (based on availability)
8.4. Market Share & Positioning Analysis (based on availability)
8.5. Vendor Landscape (based on availability)
8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CARDIAC BIO IMPLANT DEVICES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Company Profiles
- 9.2.1 Abbott
- 9.2.2 Edwards Lifesciences Corporation
- 9.2.3 Johnson & Johnson Services Inc
- 9.2.4 LivaNova PLC
- 9.2.5 Medtronic
- 9.2.6 Boston Scientific Corporation
- 9.2.7 MicroPort Scientific Corporation
- 9.2.8 Mayo Foundation For Medical Education And Research (MFMER)
- 9.2.9 ClearPoint Neuro Inc
- 9.2.10 Imricor
- 9.2.11 Biotronik
- 9.2.12 Elestim-Cardio